Research Using De-Identified Specimens: A Reminder from FDA | Bass, Berry & Sims PLC
On October 18, the Food and Drug Administration (FDA) issued a letter reminding developers of in vitro diagnostics (IVDs) that institutional review board (IRB) approval is required...